Albireo Pharma nabs Rare Pediatric Disease tag for A4250 for rare liver disorder; shares up 7% premarket [Seeking Alpha]
Albireo Pharma, Inc. (ALBO)
Last albireo pharma, inc. earnings: 3/2 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.albireopharma.com/investor-relations
Company Research
Source: Seeking Alpha
Albireo Pharma nabs Rare Pediatric Disease tag for A4250 for rare liver disorder; shares up 7% premarketThinly traded micro cap Albireo Pharma (NASDAQ:ALBO) is up7% premarket on light volume on the heels of itsannouncement that the FDA has granted Rare Pediatric Disease Designation for lead drug A4250 for the treatment of a rare life-threatening liver disease called progressive familial intrahepatic cholestasis (PFIC), an Orphan Drug indication in the U.S. and Europe.If A4250 is approved, the company will receive a Rare Pediatric Disease Priority Review Voucher that it can use for accelerated review for a future marketing application or it can sell it to a third party.A4250, an ileal bile acid transporter inhibitor, is currently in Phase 3 development for PFIC.See all stocks on the move »Now read:Dynavax: 2 Mg Vs. 8 Mg Response Is Not The 'Kiss Of Death' »
Show less
Read more
Impact Snapshot
Event Time:
ALBO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALBO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALBO alerts
High impacting Albireo Pharma, Inc. news events
Weekly update
A roundup of the hottest topics